T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

Tran, Eric, Robbins, Paul F., Lu, Yong-Chen, Prickett, Todd D., Gartner, Jared J., Jia, Li, Pasetto, Anna, Zheng, Zhili, Ray, Satyajit, Groh, Eric M., Kriley, Isaac R., Rosenberg, Steven A.·2016·New England Journal of Medicine

DOI 10.1056/nejmoa1609279

Cited by (1,002)

Items 101–200 of 1,002

Emerging strategies to target RAS signaling in human cancer therapy
Kun Chen, Yalei Zhang, Ling Mei Qian, Peng Wang · 2021 · Journal of Hematology & Oncology
Immune targets and neoantigens for cancer immunotherapy and precision medicine
Rong‐Fu Wang, Helen Y. Wang · 2016 · Cell Research
Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
Wu, Xiangyu, Li, Tianhang, Jiang, Rui, Yang, Xin, Guo, Hongqian, Yang, Rong · 2023 · Molecular Cancer
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
Shuhang Wang, Jingwei Sun, Kun Chen, Peiwen Ma, Qi Lei, Shujun Xing, Zhongzheng Cao, Shujun Sun, Zicheng Yu, Yarong Liu et al. · 2021 · BMC Medicine
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S. Chheda, Gary Kohanbash, Kaori Okada, Naznin Jahan, John Sidney, Matteo Pecoraro, Xinbo Yang, Diego A. Carrera, Kira Downey, Shruti Shrivastav et al. · 2017 · The Journal of Experimental Medicine
Best practices for bioinformatic characterization of neoantigens for clinical utility
Megan M. Richters, Huiming Xia, Katie Marie Campbell, William E. Gillanders, Obi L. Griffith, Malachi Griffith · 2019 · Genome Medicine
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M. Jaffee, Chi Van Dang, David B. Agus, Brian Michael Alexander, Kenneth Carl Anderson, Alan Ashworth, Anna D. Barker, Roshan Bastani, Sangeeta N. Bhatia, Jeffrey A. Bluestone et al. · 2017 · The Lancet Oncology
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
Rami Yossef, Eric Tran, Drew C. Deniger, Alena Gros, Anna Pasetto, Maria R. Parkhurst, Jared J. Gartner, Todd D. Prickett, Gal Cafri, Paul F. Robbins et al. · 2018 · JCI Insight
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Yueshui Zhao, Jian Ming Deng, Shuangfeng Rao, Sipeng Guo, Jing Shen, Fukuan Du, Xu Wu, Yu Chen, Mingxing Li, Meijuan Chen et al. · 2022 · Cancers
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Maria Laura De Angelis, Federica Francescangeli, Filippo La Torre, Ann Zeuner · 2019 · Frontiers in Oncology
KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment
Dias Carvalho, Patrícia, Guimarães, Carlos F., Cardoso, Ana P., Mendonça, Susana, Costa, Ângela M, Oliveira, Maria J., Velho, Sérgia · 2018 · Cancer Research
Applications of Immunogenomics to Cancer
X. Shirley Liu, Elaine R. Mardis · 2017 · Cell
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
Dyantha I. van der Lee, Rogier M. Reijmers, Maria W. Honders, Renate S. Hagedoorn, Rob C. M. de Jong, Michel G.D. Kester, Dirk M. van der Steen, Arnoud H. de Ru, Christiaan Kweekel, Helena M. Bijen et al. · 2019 · Journal of Clinical Investigation
Gene editing for immune cell therapies
Stefanie R. Bailey, Marcela Valderrama Maus · 2019 · Nature Biotechnology
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Elísabeth Pérez-Ruiz, Ignacio Melero, Joanna Kopecka, Ana Bela Sarmento‐Ribeiro, Marilina García‐Aranda, Javier De Las Rivas · 2020 · Drug Resistance Updates
Tumor-infiltrating human CD4 + regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
Mojgan Ahmadzadeh, Anna Pasetto, Lee Jia, Drew C. Deniger, Sanja Stevanović, Paul F. Robbins, Steven A. Rosenberg · 2019 · Science Immunology
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition
Helen Adderley, Fiona Helen Blackhall, Colin R. Lindsay · 2019 · EBioMedicine
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
Nikolaos Zacharakis, Lutfi Huq, Samantha J. Seitter, Sanghyun Peter Kim, Jared J. Gartner, Sivasish Sindiri, Victoria K. Hill, Yong F. Li, Biman C. Paria, Satyajit Ray et al. · 2022 · Journal of Clinical Oncology
Targeting public neoantigens for cancer immunotherapy
Alexander H. Pearlman, Michael S. Hwang, Maximilian F. Konig, Emily Han-Chung Hsiue, Jacqueline Douglass, Sarah R. DiNapoli, Brian J. Mog, Chetan Bettegowda, Drew M. Pardoll, Sandra B. Gabelli et al. · 2021 · Nature Cancer
Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
Irene Scarfò, Marcela Valderrama Maus · 2017 · Journal for ImmunoTherapy of Cancer
Tumor Evolution as a Therapeutic Target
Nabil Amirouchene-Angelozzi, Charles Swanton, Alberto Bardelli · 2017 · Cancer Discovery
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
Sanghyun Peter Kim, Nolan R. Vale, Nikolaos Zacharakis, Sri Krishna, Zhiya Yu, Billel Gasmi, Jared J. Gartner, Sivasish Sindiri, Parisa Malekzadeh, Drew C. Deniger et al. · 2022 · Cancer Immunology Research
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors
Lee, Jessica K., Sivakumar, Smruthy, Schrock, Alexa B., Madison, Russell, Fabrizio, David, Gjoerup, Ole, Ross, Jeffrey S., Frampton, Garrett M., Napalkov, Pavel, Montesion, Meagan et al. · 2022 · npj Precision Oncology
Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
Baisheng Lin, Likun Du, Hongmei Li, Xiao Ming Zhu, Liao Cui, Xiaosong Li · 2020 · Biomedicine & Pharmacotherapy
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
Zhidong Wang, Yu J Cao · 2020 · Frontiers in Immunology
Immunotherapies: Exploiting the Immune System for Cancer Treatment
Jeffrey Koury, Mariana Lucero, Caleb Cato, Lawrence Chang, Joseph Geiger, Denise Henry, Jennifer Hernandez, Fion Hung, Preet Kaur, Garrett Teskey et al. · 2018 · Journal of Immunology Research
Colorectal Cancers: An Update on Their Molecular Pathology
Kentaro Inamura · 2018 · Cancers
Tumor immune microenvironment in head and neck cancers
Samantha M. Y. Chen, Alexandra L. Krinsky, Rachel A. Woolaver, Xiaoguang Wang, Zhangguo Chen, Jing Hong Wang · 2020 · Molecular Carcinogenesis
RAS: Striking at the Core of the Oncogenic Circuitry
Gimple, Ryan C., Wang, Xiuxing · 2019 · Frontiers in Oncology
Bispecific antibodies targeting mutant RAS neoantigens
Douglass, Jacqueline, Hsiue, Emily Han-Chung, Mog, Brian J., Hwang, Michael S., DiNapoli, Sarah R., Pearlman, Alexander H., Miller, Michelle S., Wright, Katharine M., Azurmendi, P. Aitana, Wang, Qing et al. · 2021 · Science Immunology
The current understanding on the impact of KRAS on colorectal cancer
Meng, Mingjing, Zhong, Keying, Jiang, Ting, Liu, Zhongqiu, Kwan, Hiu Yee, Su, Tao · 2021 · Biomedicine & Pharmacotherapy
Mismatch Repair-Deficient Colorectal Cancer: Building on Checkpoint Blockade
Zhaohui Jin, Frank A. Sinicrope · 2022 · Journal of Clinical Oncology
Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Samuel I. Kim, Christopher R. Cassella, Katelyn T. Byrne · 2021 · Frontiers in Immunology
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
Gal Cafri, Rami Yossef, Anna Pasetto, Drew C. Deniger, Yong‐Chen Lu, Maria R. Parkhurst, Jared J. Gartner, Lee Jia, Satyajit Ray, Lien T. Ngo et al. · 2019 · Nature Communications
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Mohammad Hossein Kazemi, Maryam Sadri, Alireza Najafi, Ali R. Rahimi, Zeinab Baghernejadan, Hossein Khorramdelazad, Reza Falak · 2022 · Frontiers in Immunology
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Conway, Jake R., Kofman, Eric, Mo, Shirley S., Elmarakeby, Haitham, Van Allen, Eliezer · 2018 · Genome Medicine
Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
David Gfeller, Michal Bassani‐Sternberg · 2018 · Frontiers in Immunology
Technological advances in cancer immunity: from immunogenomics to single‐cell analysis and artificial intelligence
Xu, Ying, Su, Guan-Hua, Ma, Ding, Xiao, Yi, Shao, Zhi-Ming, Jiang, Yi-Zhou · 2021 · Signal Transduction and Targeted Therapy
Strategies for Increasing Pancreatic Tumor Immunogenicity
Burles Avner Johnson, Mark M. Yarchoan, Valerie Lee, Daniel A. Laheru, Elizabeth M. Jaffee · 2017 · Clinical Cancer Research
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
Ravi Salgia, Rebecca R. Pharaon, Isa Mambetsariev, Arin Nam, Martin Sattler · 2021 · Cell Reports Medicine
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
Chung‐Han Lee, Roman Yelensky, Karin U. Jooss, Timothy An-thy Chan · 2018 · Trends in Immunology
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
Amy Rappaport, Chrisann Kyi, Monica Lane, Meghan G. Hart, Melissa Lynne Johnson, Brian S. Henick, Chih‐Yi Liao, Amit Mahipal, Ardaman P. Shergill, Alexander I. Spira et al. · 2024 · Nature Medicine
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
Trujillo, Jonathan A., Luke, Jason J., Zha, Yuanyuan, Segal, Jeremy P., Ritterhouse, Lauren L., Spranger, Stefani, Matijevich, Karen, Gajewski, Thomas F. · 2019 · Journal for ImmunoTherapy of Cancer
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group
Leticia De Mattos‐Arruda, Miguél Vázquez, Francesca Finotello, Rosalba Lepore, E. Porta, Jasreet Hundal, Pep Amengual-Rigo, Charlotte K.Y. Ng, Alfonso Valencia, Jorge Carrillo et al. · 2020 · Annals of Oncology
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher Austin Klebanoff, Smita S. Chandran, Brian M. Baker, Sergio A. Quezada, Antoni Ribas · 2023 · Nature Reviews Drug Discovery
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Winifred M. Lo, Maria R. Parkhurst, Paul F. Robbins, Eric Tran, Yong‐Chen Lu, Lee Jia, Jared J. Gartner, Anna Pasetto, Drew C. Deniger, Parisa Malekzadeh et al. · 2019 · Cancer Immunology Research
Molecular mechanisms of the preventable causes of cancer in the United States
Erica A. Golemis, Paul A. Scheet, Tim N. Beck, Eward M. Scolnick, David J. Hunter, Ernest T. Hawk, Nancy H. Hopkins · 2018 · Genes & Development
DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
Jingcheng Wu, Wenzhe Wang, Jiucheng Zhang, Binbin Zhou, Wenyi Zhao, Zhixi Su, Xun Gu, Jian Wu, Zhan Mei Zhou, Shuqing Chen · 2019 · Frontiers in Immunology
KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer
Neeraj Lal, Brian S. White, Ghaleb Goussous, Oliver J. Pickles, Mike J. Mason, Andrew David Beggs, Philippe Tanière, Benjamin E. Willcox, Justin Guinney, Gary Middleton · 2017 · Clinical Cancer Research
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
Alena Gros, Eric Tran, Maria R. Parkhurst, Sadia Ilyas, Anna Pasetto, Eric M. Groh, Paul F. Robbins, Rami Yossef, Andrea García-Garijo, Carlos Alberto Fajardo et al. · 2019 · Journal of Clinical Investigation
Colorectal cancer immunotherapy-Recent progress and future directions
Wen Zhao, Lujia Jin, Peng Chen, Dingchang Li, Wenxing Gao, Guanglong Dong · 2022 · Cancer Letters
T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Drew C. Deniger, Anna Pasetto, Paul F. Robbins, Jared J. Gartner, Todd D. Prickett, Biman C. Paria, Parisa Malekzadeh, Lee Jia, Rami Yossef, Michelle M. Langhan et al. · 2018 · Clinical Cancer Research
Antigen processing and presentation in cancer immunotherapy
Maxwell Y Lee, Jun W. Jeon, Cem M. Sievers, Clint Tanner Allen · 2020 · Journal for ImmunoTherapy of Cancer
Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
Molina-Arcas, Miriam, Downward, Julian · 2024 · Cancer Cell
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
Yugang Guo, Kewen Lei, Li Tang · 2018 · Frontiers in Immunology
Immunotherapy for Colorectal Cancer
Patrick McKay Boland, Wen Ma · 2017 · Cancers
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade
Lee P. Richman, Robert H. Vonderheide, Andrew J. Rech · 2019 · Cell Systems
Detecting Tumor Antigen-Specific T Cells via Interaction-Dependent Fucosyl-Biotinylation
Liu, Zilei, Li, Jie P., Chen, Mingkuan, Wu, Mengyao, Shi, Yujie, Li, Wei, Teijaro, John R., Wu, Peng · 2020 · Cell
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
Amrendra Kumar, Reese Watkins, Anna E. Vilgelm · 2021 · Frontiers in Immunology
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
Sandra Wagner, Christina Susanne Mullins, Michael Linnebacher · 2018 · World Journal of Gastroenterology
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Maria Karasarides, Alexandria P. Cogdill, Paul B. Robbins, Michaela Bowden, Elizabeth M. Burton, Lisa Helene Butterfield, Alessandra Cesano, Christian Hammer, Cara Haymaker, Christine E. Horak et al. · 2022 · Cancer Immunology Research
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas
Devin Dersh, James D. Phelan, Megan E. Gumina, Boya Wang, Jesse H. Arbuckle, Jaroslav Hollý, Rigel J. Kishton, Tovah E. Markowitz, Mina O. Seedhom, Nathan Fridlyand et al. · 2020 · Immunity
Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers
Chunhong Zheng, Joseph N Fass, Yi-Ping Shih, Andrew J. Gunderson, Nelson Sanjuan Silva, Huayu Huang, Brady M. Bernard, Venkatesh Rajamanickam, Joseph Slagel, Carlo Bruno Bifulco et al. · 2022 · Cancer Cell
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities
Olga S. Blomberg, Lorenzo Spagnuolo, Karin E. de Visser · 2018 · Disease Models & Mechanisms
High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39 + CD8 + T cells
Ting Liu, Jizhou Tan, Minhao Wu, Wenzhe Fan, Jialiang Wei, Bowen Zhu, Jian Ming Guo, Shutong Wang, Penghui Zhou, Hui Zhang et al. · 2020 · Gut
Precision oncology in the age of integrative genomics
Chandan Kumar‐Sinha, Arul M. Chinnaiyan · 2018 · Nature Biotechnology
Determinants for Neoantigen Identification
Andrea García-Garijo, Carlos Alberto Fajardo, Alena Gros · 2019 · Frontiers in Immunology
A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
Zhang, Ziyang, Rohweder, Peter J., Ongpipattanakul, Chayanid, Basu, Koli, Bohn, Markus-Frederik, Dugan, Eli J., Steri, Veronica, Hann, Byron, Shokat, Kevan M., Craik, Charles S. · 2022 · Cancer Cell
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies
Marta Chiaravalli, Michele Reni, Eileen Mary O'Reilly · 2017 · Cancer Treatment Reviews
Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
Iris Z. Uras, Herwig Peter Moll, Emilio Casanova · 2020 · International Journal of Molecular Sciences
Neoantigen quality, not quantity
Nicholas McGranahan, Charles Swanton · 2019 · Science Translational Medicine
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
Smita S. Chandran, Jiaqi Ma, Martin G. Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Yong Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu et al. · 2022 · Nature Medicine
The landscape of T cell antigens for cancer immunotherapy
Aviyah Peri, Nadja Salomon, Yochai Wolf, Sebastian Kreiter, Mustafa Diken, Yardena Samuels · 2023 · Nature Cancer
New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Yang, Haitang, Liang, Shun-Qing, Schmid, Ralph A., Peng, Ren-Wang · 2019 · Frontiers in Oncology
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma
Aaron Scott Mansfield, Tobias Peikert, James B. Smadbeck, Julia B.M. Udell, Enrique Garcia-Rivera, Laura R. Elsbernd, Courtney L. Erskine, Virginia P. Van Keulen, Farhad Kosari, Stephen J. Murphy et al. · 2018 · Journal of Thoracic Oncology
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Qiaofei Liu, Jiayi Li, Huaijin Zheng, Sen Yang, Yuze Hua, Nan Huang, Jorg H. Kleeff, Quan Liao, Wenming Wu · 2023 · Molecular Cancer
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma
Joshua R. Veatch, Sylvia M. Lee, Matthew Fitzgibbon, I‐Ting Chow, Brenda L. Jesernig, Tom Schmitt, Ying Kong, Julia Kargl, A. McGarry Houghton, John A. Thompson et al. · 2018 · Journal of Clinical Investigation
High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
Malcolm J. W. Sim, Jinghua Lu, Matthew K. Spencer, Francis R. Hopkins, Eric Tran, Steven A. Rosenberg, Eric O. Long, Peter D. Sun · 2020 · Proceedings of the National Academy of Sciences
The expanding role of immunotherapy
Juan Martín-Liberal, María Ochoa de Olza, Cinta Hierro, Alena Gros, Jordi Ahnert Rodon, Josep M. Tabernero · 2017 · Cancer Treatment Reviews
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms
Xiaojuan Yang, Hong Kun Wu · 2024 · Journal of Hematology & Oncology
The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer
Nick van Dijk, Samuel Aaron Funt, Christian U. Blank, Thomas B. Powles, Jonathan E. Rosenberg, Michiel S. van der Heijden · 2018 · European Urology
Computational Prediction and Validation of Tumor-Associated Neoantigens
Vladimir Roudko, Benjamin D. Greenbaum, Nina Bhardwaj · 2020 · Frontiers in Immunology
Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
Li, Qing-Hai, Wang, Ying-Zhao, Tu, Jian, Liu, Chu-Wei, Yuan, Yu-Jie, Lin, Run, He, Wei-Ling, Cai, Shi-Rong, He, Yu-Long, Ye, Jin-Ning · 2020 · Gastroenterology Report
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
Zihai Li, Wenru Song, Mark P. Rubinstein, Delong Liu · 2018 · Journal of Hematology & Oncology
Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens
Parisa Malekzadeh, Rami Yossef, Gal Cafri, Biman C. Paria, Frank J. Lowery, Mohammad S. Jafferji, Meghan L. Good, Abraham Sachs, Amy R. Copeland, Sanghyun Peter Kim et al. · 2020 · Clinical Cancer Research
KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
Sahar F. Bannoura, Husain Yar Khan, Asfar Sohail Azmi · 2022 · Frontiers in Oncology
Predictive biomarkers for response to immune checkpoint inhibition
Benjamin Shum, James Larkin, Samra Turajlic · 2021 · Seminars in Cancer Biology
Mutation-Derived Neoantigens for Cancer Immunotherapy
John C. Castle, Mohamed Uduman, Simarjot Singh Pabla, Robert Benjamin Stein, Jennifer S. Buell · 2019 · Frontiers in Immunology
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma
Jeffrey C. Thompson, Christiana W. Davis, Charuhas G. Deshpande, Wei‐Ting Hwang, Seth Jeffries, Alexander Chan Chi Huang, Tara C. Mitchell, Corey Jay Langer, Steven Μ. Albelda · 2020 · Journal for ImmunoTherapy of Cancer
Adoptive cell therapy for cancer treatment
Shi Du, Jingyue Yan, Yonger Xue, Yichen Zhong, Yizhou Dong · 2023 · Exploration
Endogenous T cells prevent tumor immune escape following adoptive T cell therapy
Scott R. Walsh, Boris Simovic, Lan Chen, Donald J. Bastin, Andrew Nguyen, Kyle B. Stephenson, Talveer S. Mandur, Jonathan L. Bramson, Brian Dennis Lichty, Yonghong Wan · 2019 · Journal of Clinical Investigation
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Bear, Adham S., Blanchard, Tatiana, Cesare, Joseph, Ford, Michael J., Richman, Lee P., Xu, Chong, Baroja, Miren L., McCuaig, Sarah, Costeas, Christina, Gabunia, Khatuna et al. · 2021 · Nature Communications
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
Andrew J. Poole, Vijaykumar Karuppiah, Annabelle Hartt, Jaafar N. Sleiman Haidar, Sylvie Moureau, Tomasz Dobrzycki, Conor Hayes, Christopher N. Rowley, J.C. Dias, Stephen J Harper et al. · 2022 · Nature Communications
Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction
Markus Müller, Florian Huber, Marion Arnaud, Anne I. Kraemer, Emma Ricart Altimiras, Justine Michaux, Marie Taillandier-Coindard, Johanna Chiffelle, Baptiste Murgues, Talita Gehret et al. · 2023 · Immunity
TCRmodel2: high-resolution modeling of T cell receptor recognition using deep learning
Rui Ming Yin, Helder Veras Ribeiro Filho, Valerie C. L. Lin, Ragul Gowthaman, Melyssa Cheung, Brian G. Pierce · 2023 · Nucleic Acids Research
Immunotherapy for Glioblastoma: Adoptive T-cell Strategies
Bryan D. Choi, Marcela Valderrama Maus, Carl H. June, John Howard Sampson · 2018 · Clinical Cancer Research
TSNAdb: A Database for Tumor-Specific Neoantigens from Immunogenomics Data Analysis
Jingcheng Wu, Wenyi Zhao, Binbin Zhou, Zhixi Su, Xun Gu, Zhan Mei Zhou, Shuqing Chen · 2018 · Genomics Proteomics & Bioinformatics
Induction of neoantigen-reactive T cells from healthy donors
Muhammad Ali, Zsófia Földvári, Eirini Giannakopoulou, Maxi-Lu Böschen, Erlend Strønen, Weiwen Yang, Mireille Toebes, Benjamin Schubert, Oliver Kohlbacher, Ton N. Schumacher et al. · 2019 · Nature Protocols
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, Yi Lin, Biao An, Xiang He, Xia Zhao · 2022 · Frontiers in Immunology
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada · 2023 · Immunity